Michael S. Perry's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 7,819 Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharma Inc | Michael S. Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2025 | 7,819 | 123,059 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Sale of securities on an exchange or to another person at price $ 61.03 per share. | 05 Dec 2025 | 16,250 | 115,240 (0%) | 0% | 61.0 | 991,738 | Common Stock |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Grant, award, or other acquisition of securities at price $ 22.99 per share. | 18 Dec 2024 | 16,733 | 131,490 (0%) | 0% | 23.0 | 384,692 | Common Stock |
| Arrowhead Pharma Inc | Michael Perry S. | Director | Grant, award, or other acquisition of securities at price $ 25.41 per share. | 15 Dec 2023 | 14,987 | 114,754 (0%) | 0% | 25.4 | 380,820 | Common Stock |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 7,867 | 99,767 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 4,593 | 4,593 | - | - | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director | Sale of securities on an exchange or to another person at price $ 7.18 per share. | 21 Nov 2022 | 150,000 | 229,543 | - | 7.2 | 1,077,000 | Common Stock |
| AVITA Medical Inc | Michael S. Perry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 150,000 | 0 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael S. Perry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.99 per share. | 21 Nov 2022 | 150,000 | 379,543 | - | 6.0 | 898,500 | Common Stock |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,450 | 6,900 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,980 | 300,983 | - | 0 | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jun 2022 | 23,754 | 297,958 | - | 0 | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 23,753 | 326,564 | - | 0 | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 23 Feb 2022 | 10,812 | 321,712 | - | 8.7 | 94,497 | Common Stock |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 5,960 | 332,524 | - | 0 | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 3,450 | 3,450 | - | - | Stock Options (Right to Buy) | |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Sale of securities on an exchange or to another person at price $ 64.30 per share. | 03 Jan 2022 | 2,628 | 87,372 (0%) | 0% | 64.3 | 168,980 | Common Stock |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Sale of securities on an exchange or to another person at price $ 65.12 per share. | 03 Jan 2022 | 1,600 | 85,772 (0%) | 0% | 65.1 | 104,192 | Common Stock |
| Arrowhead Pharma Inc | Michael S. Perry | Director | Sale of securities on an exchange or to another person at price $ 66.25 per share. | 03 Jan 2022 | 272 | 85,500 (0%) | 0% | 66.3 | 18,020 | Common Stock |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 23,820 | 302,811 | - | - | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 23,820 | 278,991 | - | - | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 23,800 | 255,171 | - | - | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 13,800 | 13,800 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 13,800 | 13,800 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 13,800 | 13,800 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 23,754 | 248,858 | - | 0 | Common Stock | |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.68 per share. | 01 Sep 2021 | 11,220 | 237,638 | - | 20.7 | 232,030 | Common Stock |
| AVITA Medical Inc | Michael S. Perry | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.33 per share. | 02 Jun 2021 | 23,000 | 225,104 | - | 17.3 | 398,590 | Common Stock |